Jubilant Biosys Limited
Eswara Murali Satyavarapu holds a Master of Business Administration in Marketing Research from Manipal University Jaipur and a Doctor of Philosophy from the University of Calcutta. With extensive experience in DMPK, Satyavarapu currently serves as a Senior Research Scientist at Jubilant Biosys Limited, following a position as a Specialist in DMPK at Aurigene Pharmaceutical Services Limited. Previous roles include Junior Research Fellow and Senior Research Fellow at CSIR-Indian Institute of Chemical Biology (IICB)-Kolkata, focusing on pre-clinical research of novel anti-cancer leads, including toxicity studies in rodents. Satyavarapu's academic background includes a PG Diploma in Patents Law and Intellectual Property Rights from NALSAR University, an M.S. in Natural Products from the National Institute of Pharmaceutical Education and Research, and a B.Pharmacy from Acharya Nagarjuna University.
This person is not in any teams
This person is not in any offices
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.